Cargando…

Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant

Complications of cirrhosis and portal hypertension (PH) can be reduced by statin therapy. The common loss‐of‐function variant p.V174A in the solute carrier organic anion transporter gene 1B1 (SLCO1B1) gene encoding the organic anion transporting polypeptide 1B1 results in decreased hepatic uptake of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merkel, Melissa, Schneider, Christina, Greinert, Robin, Zipprich, Alexander, Ripoll, Cristina, Lammert, Frank, Reichert, Matthias C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485882/ https://www.ncbi.nlm.nih.gov/pubmed/34558822 http://dx.doi.org/10.1002/hep4.1753

Ejemplares similares

Common NOD2 Risk Variants as Major Susceptibility Factors for Bacterial Infections in Compensated Cirrhosis
por: Reichert, Matthias Christian, et al.
Publicado: (2019)

Evaluation of the definition of hyperdynamic circulation in patients with cirrhosis and ascites
por: Ripoll, Cristina, et al.
Publicado: (2022)

SLCO1B1 Polymorphisms and Statin-Induced Myopathy
por: Stewart, Alison
Publicado: (2013)

SLCO1B1 Polymorphism is not associated with Risk of Statin-Induced Myalgia/Myopathy in a Czech Population
por: Hubáček, Jaroslav A., et al.
Publicado: (2015)

SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria
por: Sortica, Vinicius A, et al.
Publicado: (2017)

Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations
por: Nagy, Agnes, et al.
Publicado: (2015)

A Cost–Consequence Analysis of Preemptive SLCO1B1 Testing for Statin Myopathy Risk Compared to Usual Care
por: Brunette, Charles A., et al.
Publicado: (2021)

Statin treatment effectiveness and the SLCO1B1*5 reduced function genotype: Long‐term outcomes in women and men
por: Türkmen, Deniz, et al.
Publicado: (2022)

Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results
por: Zhou, Yitian, et al.
Publicado: (2022)

Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users
por: Jansen, Marleen E., et al.
Publicado: (2023)

A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance
por: Bigossi, Margherita, et al.
Publicado: (2023)

Hepatic Arterial Vasodilation Is Independent of Portal Hypertension in Early Stages of Cirrhosis
por: Moeller, Miriam, et al.
Publicado: (2015)

Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers
por: Song, Gonjin, et al.
Publicado: (2021)

Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with Familial Hypercholesterolemia: a case report
por: Dagli-Hernandez, Carolina, et al.
Publicado: (2021)

SLCO1B1: Application and Limitations of Deep Mutational Scanning for Genomic Missense Variant Function
por: Zhang, Lingxin, et al.
Publicado: (2021)

Meta-Analysis of the SLCO1B1 c.521T>C Variant Reveals Slight Influence on the Lipid-Lowering Efficacy of Statins
por: Dou, Ye, et al.
Publicado: (2015)

Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants
por: Lönnberg, K. Ivar, et al.
Publicado: (2023)

Chronic Enteropathy Associated with Solute Carrier Organic Anion Transporter Family, Member 2A1 (SLCO2A1) with Positive Immunohistochemistry for SLCO2A1 Protein
por: Ariake, Chizuru, et al.
Publicado: (2022)

A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy
por: Turongkaravee, Saowalak, et al.
Publicado: (2021)

A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics
por: Lehtisalo, Minna, et al.
Publicado: (2022)

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine
por: Calleja, Sofía, et al.
Publicado: (2023)

Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis
por: Hollenbach, Marcus, et al.
Publicado: (2017)

Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
por: Taylor, Zachary L., et al.
Publicado: (2021)

SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
por: Carr, D F, et al.
Publicado: (2013)

SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort
por: Magavern, Emma F., et al.
Publicado: (2023)

Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis
por: Nakanishi, Takeo, et al.
Publicado: (2015)

Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case–Control Studies
por: Hou, Qingtao, et al.
Publicado: (2015)

Polymorphic variants of SLCO1B1 in neonatal hyperbilirubinemia in China
por: Liu, Jiebo, et al.
Publicado: (2013)

A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter
por: Umeno, Junji, et al.
Publicado: (2015)

Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis
por: Lee, Sihoon, et al.
Publicado: (2016)

Indoxyl Sulfate Down-Regulates SLCO4C1 Transporter through Up-Regulation of GATA3
por: Akiyama, Yasutoshi, et al.
Publicado: (2013)

Chronic Enteropathy Associated with SLCO2A1 with Pachydermoperiostosis
por: Tsuzuki, Yoshikazu, et al.
Publicado: (2020)

Pharmacogenetic analysis of inter-ethnic variability in the uptake transporter SLCO1B1 gene in Colombian, Mozambican, and Portuguese populations
por: Nega, Mulata Haile, et al.
Publicado: (2023)

Association between SLCO1B1 −521T>C and −388A>G polymorphisms and risk of statin-induced adverse drug reactions: A meta-analysis
por: Jiang, Jiajia, et al.
Publicado: (2016)

SLCO1B1 genetic variation and hormone therapy in menopausal women
por: Moyer, Ann M., et al.
Publicado: (2018)

Ethylmethylhydroxypyridine Succinate Is an Inhibitor but Not a Substrate of ABCB1 and SLCO1B1
por: Shchulkin, Aleksey V., et al.
Publicado: (2023)

A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy
por: Jimbo, Keisuke, et al.
Publicado: (2020)

Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis
por: Ninomiya, Kohei, et al.
Publicado: (2022)

Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c.388A>G Variant Is Determinant of Increased Atorvastatin Response
por: Rodrigues, Alice C., et al.
Publicado: (2011)

Characterization of SLCO5A1/OATP5A1, a Solute Carrier Transport Protein with Non-Classical Function
por: Sebastian, Katrin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4aeh9b0qab8nlat7vva8o7jpjr